ICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.
- Revenue
- +4.37%
- EPS
- +864.3%
- Free cash flow
- +292.2%
- Total debt
- −12.3%
Quarter to September 2026, against a year earlier
Follow ICUI
Alert me
ICU Medical, Inc. (ICUI) Gross margin
ICU Medical, Inc.'s gross margin over the twelve months to 30 September 2026 was 40.3%, up 3.4 percentage points from fiscal 2025 (36.8%). Over the past ten years it has ranged from 30.6% (fiscal 2022) to 53.1% (fiscal 2016); the current reading is higher than 55% of that period. That is below the Medical Instruments & Supplies industry median of 53.6% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 36.8% | 2.22 |
| FY2024 | 34.6% | 1.87 |
| FY2023 | 32.8% | 2.15 |
| FY2022 | 30.6% | (6.74) |
| FY2021 | 37.3% | 1.03 |
| FY2020 | 36.3% | (0.96) |
| FY2019 | 37.3% | (3.45) |
| FY2018 | 40.7% | 7.76 |
| FY2017 | 33.0% | (20.13) |
| FY2016 | 53.1% | 0.17 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 41.9% | (0.72) |
| Jun 2026 | 42.6% | 3.72 |
| Mar 2026 | 38.9% | 1.35 |
| Dec 2025 | 37.5% | 0.13 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ATRC AtriCure, Inc. compare | 76.7% |
| NVST Envista Holdings Corporation compare | 55.9% |
| TFX Teleflex Incorporated compare | 54.9% |
| WRBY Warby Parker Inc. compare | 54.8% |
| MMED MiniMed Group, Inc. compare | 53.6% |
| MMSI Merit Medical Systems, Inc. compare | 49.4% |
| ICUI ICU Medical, Inc. | 40.3% |
| STVN Stevanato Group S.p.A. compare | 29.1% |
| PLSE Pulse Biosciences, Inc compare | 26.8% |
| Medical Instruments & Supplies industry median | 53.6% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on ICUI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement